NCT02521285 2025-10-23
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT01298999 2021-11-23
Trial of a Gastrin Receptor Antagonist in Barrett's Esophagus
Columbia University
Phase 2 Completed
NCT02597712 2021-04-12
YF476 in Barrett's Esophagus
Trio Medicines Ltd.
Phase 2 Completed
NCT01097304 2017-12-19
Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed
NCT02162758 2017-05-11
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Takeda
Phase 2 Terminated
NCT00217087 2015-12-24
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Mayo Clinic
Phase 2 Completed
NCT01447927 2014-07-21
Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00411151 2011-01-20
Efficacy and Safety of Sunitinib in Metastatic Gastric Cancer
Johannes Gutenberg University Mainz
Phase 2 Completed